During the past decade, UCLA Division of Hematology Oncology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UCLA Division of Hematology Oncology" #1 sponsor was "Celgene" with 4 trials, followed by "Bristol-Myers Squibb" with 2 trials sponsored, "Chroma Therapeutics" with 1 trials sponsored, "Cyclacel Pharmaceuticals, Inc." with 1 trials sponsored and "Sunesis Pharmaceuticals" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UCLA Division of Hematology Oncology" #1 collaborator was "AbbVie" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "UCLA Division of Hematology Oncology" are "Acute Myeloid Leukemia" (3 trials), "Multiple Myeloma" (2 trials), "Acute Myelogenous Leukemia" (1 trials), "Carcinoma, Hepatocellular" (1 trials) and "Chronic Lymphocytic Leukemia" (1 trials). Many other conditions were trialed in "UCLA Division of Hematology Oncology" in a lesser frequency.

Most popular intervention types in "UCLA Division of Hematology Oncology" are "Drug" (9 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Dexamethasone" (2 trials), "BMS-936564 (Anti-CXCR4)" (1 trials), "CC-122" (1 trials), "CC-90002" (1 trials) and "CHR-2797" (1 trials). Other intervention names were less common.

The vast majority of trials in "UCLA Division of Hematology Oncology" are 9 trials for "All" genders.

Currently, there are NaN active trials in "UCLA Division of Hematology Oncology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in UCLA Division of Hematology Oncology, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in UCLA Division of Hematology Oncology, 3 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".